Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Flupentixol and Melitracen Tablets in the Treatment of Non Random Emotional Disorder

NCT04970667 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04970667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04970667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Flupentixol and Melitracen Tablets in the Treatment of Non Random Emotional Disorder
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
April 30, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

emotional disorder, neurologic disorder